| Code | 9601C | ||||||||||
| MA number | 42/0171/13-S | ||||||||||
| Product Form: | sol inf 20x100 ml (fľ.PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Fresenius Kabi s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.04.2013 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| PIL: |
PIL_Levofloxacin Kabi 5 mg_ml_sol inf_05.2025.pdf
|
| SPC: |
SPC_Levofloxacin Kabi 5 mg_ml_sol inf_05.2025.pdf
|
| Safety feature | Yes |
| Data update: | 06.11.2018 |
